Carl E. Stafstrom*, Douglas Nordli†, Andrew Lux‡ and Lionel Carmant§ *Neurology, University of Wisconsin, Madison, WI; †Neurology, Children's Memorial Hospital, Chicago, IL; ‡Pediatric Neurology, British Royal Hospital for Children, Bristol, United Kingdom and §Pediatric Neurology, Ste‐Justine Hospital, Montreal, QC, Canada Summary: Infantile spasms is a catastrophic epilepsy of childhood that poses unique challenges for the clinician. An optimal therapy is lacking, and to date there has been no animal model that sufficiently replicates clinical features, so our understanding of mechanism is incomplete. Existing therapies are limited by effectiveness, availability or both. Yet, each of these challenges offers a unique opportunity to advance clinical and basic knowledge of this developmental epilepsy. This symposium will discuss recent advances about the clinical profile, therapeutic modalities, outcome, and mechanisms of infantile spasms. Dr. Nordli will review infantile spasms presentations and clinial features, especially variants. Dr. Lux will discuss current and future treatments. Dr. Carmant will discuss outcomes of infantile spasms. Finally, Dr. Stafstrom will consider emerging animal models that might shed light on infantile spasms mechanisms.